RRML - Diffuse large B-cell lymphoma – a new look and old prognostic factors
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- February 2020 -
 
The role of neutrophil to lymp... 22
The direct deleterious effect ... 20
The usefulness of neutrophil/l... 19
Quality Control Strategy for A... 16
Genetic testing in pediatrics ... 11
Variability of ex-vivo stimula... 10
A rare case of acute myeloid l... 10
Is there a correlation between... 9
Relationships between serum pr... 8
HBV genotypes circulation in p... 8

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 20(4)/2012
XML
TXT

Diffuse large B-cell lymphoma – a new look and old prognostic factors

Camelia Dobrea, Hamed Al Salamat, Anca Roxana Lupu


Abstract:

Diffuse large B-cell lymphoma (DLBCL) accounts for about 30% of non-Hodgkin’s lymphoma (NHL) cases. The 2008 WHO Classification of Lymphoid Neoplasms recognizes several clinicopathological variants, subtypes and distinct disease entities of DLBCL. We present a review of clinical, pathological and molecular factors with implication in DLBCL behavior. Even if the golden standard therapy for CD20-positive DLBCL is still represented by R-CHOP, prognostic factor assessment could open new therapeutic perspectives.

Keywords: diffuse large B cell lymphoma,prognostic factors

 
  PDF Download full text PDF
(870 KB)
     
 
How to cite
Dobrea C, Al Salamat H, Lupu AR. Diffuse large B-cell lymphoma – a new look and old prognostic factors. Rev Romana Med Lab. 2012;20(4):307-15